Meta Biomed Co., Ltd. (KOSDAQ:059210)

South Korea · Delayed Price · Currency is KRW

3,680.00

+45.00 (1.24%)

At close: Nov 2, 2026

Market Cap	99.99B -34.0%
Revenue (ttm)	101.19B +1.8%
Net Income	16.99B -3.4%
EPS	587.04 -5.3%
Shares Out	27.17M
PE Ratio	6.27
Forward PE	5.06
Dividend	105.00 (2.85%)
Ex-Dividend Date	Jun 29, 2026

Volume	25,298
Open	3,605.00
Previous Close	3,635.00
Day's Range	3,600.00 - 3,685.00
52-Week Range	3,265.00 - 6,350.00
Beta	0.47
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Meta Biomed

Meta Biomed Co., Ltd. engages in the research, development, and production of dental and surgical materials in South Korea, Asia, Europe, the United States, and Africa. The company's dental products include endodontics, dental equipment, restorative materials, and bone graft materials. It also offers suture products comprising multifilament and monofilament products; suture materials, such as functional and orthopedic suture materials; biomaterials, that includes polymer, multifilament yarn, 3D printing filaments, and bioceramic powder; and aux... [Read more]

Industry Dental Equipment and Supplies

Founded 1990

Employees 331

Stock Exchange KOSDAQ

Ticker Symbol 059210

Full Company Profile

Financial Performance

In 2025, Meta Biomed's revenue was 102.95 billion, an increase of 9.48% compared to the previous year's 94.04 billion. Earnings were 10.99 billion, a decrease of -50.95%.

Financial Statements